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Objective: Extracranial carotid artery aneurysms (ECCAs) are extremely rare with limited information about management
options. Our purpose was to review our institution’s experience with ECCAs during 15 years and to discuss the
presentation and treatment of these aneurysms.
Methods: A retrospective review of patients diagnosed with ECCAs from 1998 to 2012 was performed. Symptoms, risk
factors, etiology, diagnostic methods, treatments, and outcomes were reviewed.
Results: During the study period, 141 aneurysms were diagnosed in 132 patients (mean age, 61 years; 69 men). There
were 116 (82%) pseudoaneurysms and 25 (18%) true aneurysms; 69 (49%) aneurysms were asymptomatic, whereas 72
(52%) had symptoms (28 painless masses; 10 transient ischemic attacks; 10 vision symptoms; 9 ruptures; 8 strokes;
4 painful mass; 1 dysphagia; 1 tongue weakness; 1 bruit). Causes of true aneurysms included ﬁbromuscular dysplasia in
15 patients, Ehlers-Danlos syndrome in three, Marfan syndrome in one, and uncharacterized connective tissue diseases in
two. Of 25 true aneurysms, 11 (44%) were symptomatic; 15 (60%) true aneurysms underwent open surgical treatment,
whereas 10 (40%) were managed nonoperatively. Postoperative complications included one stroke during a mean follow-
up of 31 months (range, 0-166 months). No aneurysms managed nonoperatively required intervention during a mean
follow-up of 77 months (range, 1-115 months). Of 116 pseudoaneurysms, 60 (52%) were symptomatic; 33 (29%)
pseudoaneurysms underwent open surgery, 18 (15%) underwent endovascular intervention, and 65 (56%) were managed
medically. Pseudoaneurysm after endarterectomy (28 patients; 24%) presented at a mean of 82 months from the surgical
procedure. Mean follow-up for all aneurysms was 33.9 months. One (0.7%) aneurysm-related death occurred (rupture
treated palliatively). No patient undergoing nonoperative management suffered death or major morbidity related to the
aneurysm. Nonoperative management was more common in asymptomatic patients (71%) than in symptomatic patients
(31%).
Conclusions: ECCAs are uncommon and may be manifested with varying symptoms. All segments of the carotid artery are
susceptible, although the internal is most commonly affected. Open surgical intervention was more common in patients
with symptoms and with true aneurysms. Patients with pseudoaneurysms were more likely to undergo endovascular
intervention. Nonoperative treatment is safe in selected patients. (J Vasc Surg 2015;61:389-93.)In 1805, Sir Astley Cooper ligated the common
carotid artery in an attempt to treat an aneurysm of the
artery. The surgery was successful but the patient died
48 hours later.1 Dimtza performed the ﬁrst successful
carotid aneurysm excision in 1952 using an end-to-end
anastomosis.2 Beall et al were the ﬁrst to report the use
of a prosthetic graft to replace the carotid for aneurysmal
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carotid artery aneurysms (ECCAs).
Aneurysms of the extracranial carotid artery are rare
and account for less than 1% of all arterial aneurysms.4-7
In the literature, the most common location is the com-
mon carotid artery near the bifurcation. The mid to distal
internal carotid artery is the second most common loca-
tion.8 Atherosclerosis is the most common cause, especially
in older patients, but trauma, ﬁbromuscular dysplasia, prior
surgery, congenital defects, infection, and radiation can all
predispose to aneurysmal degeneration.5,8 Large series of
the management of ECCAs in the era of endovascular
intervention are rare. Herein we present our institution’s
experience with the surgical and medical management of
ECCAs during the past 15 years and discuss the presenta-
tion and treatment of these aneurysms.METHODS
After Institutional Review Board approval, a retrospec-
tive review of all patients in the Mayo Clinic System diag-
nosed with ECCA from January 1, 1998, through June389
Table I. Presentation, treatment, and follow-up of




Mean age, years (P ¼ .08) 67 60
Age range 37-91 19-95
Gender
Men (c2, P ¼ .10) 8 (35) 61 (56)
Women 15 (65) 48 (44)
Bilateral 2 (8) 7 (6)
Symptoms 11 (44) 60 (52)
Mass 6 (24) 20 (17)
Pain 2 (8) 2 (2)
Bleed 0 9 (8)
Stroke/transient ischemic
attack
3 (12) 13 (11)
Other 0 (0) 16 (14)
Treatment
Open surgery 15 (60) 33 (28)
Endovascular 0 (0) 18 (16)
Medical 10 (40) 65 (56)
Mean follow-up, months 31 30
Follow-up range, months 0-167 0-153
Data are presented as number (%) unless otherwise indicated.
Table II. Endovascular interventions on extracranial
carotid pseudoaneurysms
No. Percentage
Total aneurysms treated endovascularly 18 100
Covered stent 4 22
Uncovered stent with aneurysm coiling 11 61
Carotid sacriﬁce/embolization 3 17
Table III. Medical treatment of extracranial carotid
artery aneurysms (ECCAs)
No. Percentage
Total aneurysms treated medically
(no intervention)
75 100
Aspirin 325 mg 3 4
Aspirin 81 mg 40 53.3
Aspirin 81 mg and clopidogrel 75 mg 4 5.3
Clopidogrel 75 mg 1 1.3
Warfarin 7 9.3
Warfarin and aspirin 81 mg 1 1.3
Serial imaging and close follow-up 19 25.3
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was waived because of the retrospective nature of the study.
This consecutive series included patients at three distinct
geographic locations: Rochester, Minnesota; Jacksonville,
Florida; and Phoenix, Arizona. Medical records of all pa-
tients were reviewed and included radiology reports, clin-
ical notes, and operative reports. Patient demographic
information, medical and surgical history, aneurysm size,
causes, symptoms, medical and surgical treatments, opera-
tive details, and complications were recorded. Follow-up
was recorded with clinical notes and repeated imaging.
The distinction between true aneurysms and pseudoaneur-
ysms was determined clinically or radiographically by the
physicians involved in the care of the patients. When dis-
crepancies arose regarding aneurysm classiﬁcation, the eti-
ology, pathology reports, and radiographic images were
reviewed by the authors.
Indications for intervention included symptoms, sus-
pected infection, increasing aneurysm size, and size. Strict
size cutoffs were not used; the treating clinicians made de-
terminations about size and the need for intervention on
the basis of etiology, aneurysm location, and aneurysm
morphology. Basic demographic information and aneu-
rysm characteristics were recorded. When measurements
were not documented in the record, one of the authors
of this report reviewed the images and calculated measure-
ments. Open surgical intervention was typically performed
under general anesthesia. Shunts and electroencephalo-
graphic monitoring were used selectively at the surgeon’s
discretion. Endovascular procedures were typically per-
formed under conscious sedation unless hemodynamic
instability mandated general anesthesia. Complications
including bleeding, infection, cranial nerve injury, stroke,and death were recorded. Statistical analysis was conducted
by t-tests and c2 analysis with Microsoft Excel.RESULTS
During the 15-year study period, 141 ECCAs in 132
patients seeking treatment at the Mayo Clinic were identi-
ﬁed and included for review (Table I). The mean age was
61 years (range, 19-95 years), and 69 patients (52%)
were men. Bilateral aneurysms were present in nine patients
(7%). Diagnosis was made by magnetic resonance imaging
of 61 aneurysms (43%), by computed tomography of 40
(28%), by ultrasound examination of 29 (21%), by angiog-
raphy of nine (6.5%), and with clinical evidence of rupture
but no imaging of two (1.5%). Of these aneurysms, 114
(81%) involved the internal carotid, 11 (8%) the common
carotid, 15 (10%) the bifurcation, and 1 (1%) the external
carotid. There were 116 (82%) pseudoaneurysms and 25
(18%) true aneurysms; 72 aneurysms (52%) were mani-
fested with symptoms (28 painless mass; 10 transient
ischemic attacks; 10 vision symptoms; 9 ruptures; 8 strokes;
4 painful mass; 1 dysphagia; 1 tongue weakness; 1 bruit).
Intervention was undertaken in 66 aneurysms, 48 by
open surgery and 18 by endovascular intervention. Endo-
vascular interventions included covered stents, uncovered
stents with aneurysm coiling, and carotid sacriﬁce
(Table II). Distal embolic protection devices were used at
the provider’s discretion. When carotid embolization was
considered during endovascular intervention, a balloon
occlusion test was performed before embolization.
Seventy-ﬁve aneurysms were treated nonoperatively; medi-
cal therapy included aspirin, anticoagulation, or serial imag-
ing as determined by the treating clinician (Table III).
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One (0.7%) aneurysm-related death occurred (rupture
treated palliatively). No patient undergoing nonoperative
treatment suffered death or major morbidity related
to the aneurysm. One pseudoaneurysm diagnosed in a
77-year-old and treated nonoperatively with aspirin
81 mg demonstrated a small amount of growth during a
9-year follow-up period but was not operated on because
of the patient’s age and slow growth of the aneurysm.
Nonoperative treatment was more common in asymptom-
atic patients (71%) than in symptomatic patients (31%) and
in patients whose aneurysms demonstrated stability before
consultation at our institution.
True aneurysms. Of 25 true aneurysms, 11 (44%)
were manifested with symptoms. The average diameter of
true aneurysms causing symptoms was 22.8 mm compared
with 12.9 mm in asymptomatic aneurysms; 15 (60%) true
aneurysms (average diameter, 21.2 mm) underwent open
surgical treatment, whereas 10 (40%) were treated nonop-
eratively (average diameter, 12.0 mm). Surgical procedures
included 14 (93%) aneurysmectomies with reconstruction
(seven end-to-end anastomoses, four saphenous in-
terpositions, three prosthetic interpositions) and one (7%)
aneurysmorrhaphy. Postoperative complications included
one stroke during a mean follow-up of 31 months (range,
0-166months).The strokeoccurred 8hours postoperatively.
At exploration, there was considerable thrombus lining the
polytetraﬂuoroethylene graft (W. L. Gore & Associates,
Newark, Del). The graft was excised, and the artery was
reconstructed with saphenous vein. The patient had no long-
term sequelae.
No aneurysms treated nonoperatively progressed to
need treatment during a mean follow-up of 77 months
(range, 1-115 months). The possible cause of true aneu-
rysms was ﬁbromuscular dysplasia in 15 patients, Ehlers-
Danlos syndrome in three, Marfan syndrome in one, and
uncharacterized connective tissue diseases in two. The an-
eurysms were attributed to these diseases when preopera-
tive diagnoses were known, pathologic examination was
consistent with the disease, or postoperative testing
revealed the presence of the disease. Some pathologic spec-
imens demonstrated characteristics of connective tissue dis-
ease that were not speciﬁc for ﬁbromuscular dysplasia,
Ehlers-Danlos syndrome, or Marfan syndrome. These
were classiﬁed as uncharacterized. Other true aneurysms
without identiﬁable sources were attributed to idiopathic
causes but could have been inﬂuenced by hypertension,
dyslipidemia, or genetics.
Pseudoaneurysms. Of 116 pseudoaneurysms, 60
(52%) were symptomatic. Aneurysms causing symptoms
had an average diameter of 17.1 mm compared with an
average of 10.5 mm in asymptomatic pseudoaneurysms
(P < .01). Thirty-three (29%) pseudoaneurysms (average
diameter, 20.9 mm) underwent open surgery, 18 (15%)
pseudoaneurysms (average diameter, 14.5 mm) underwent
endovascular intervention, and 65 (56%) pseudoaneurysms
(average diameter, 10.2 mm) were managed medically; 42
(65%) aneurysms managed medically were treated withantiplatelet agents (35 single-agent, ﬁve dual-agent), and
seven (11%) were treated with anticoagulation.
Pseudoaneurysms at the site of prior endarterectomy
accounted for 28 (24%) of all pseudoaneurysms. Pseudoa-
neurysm after endarterectomy presented at a mean of
82 months from the time of surgery. All of the affected ar-
teries were originally patched (79% Dacron, 7% saphenous
vein, 4% bovine pericardium, 10% unknown patch). Seven-
teen (61%) pseudoaneurysms (average diameter, 24.4 mm)
at the site of prior endarterectomy were treated surgically,
four (14%) were treated endovascularly (average diameter,
26.8 mm), and seven (25%) were treated medically
(average diameter, 15.8 mm). Two pseudoaneurysms
caused by infection of a prosthetic patch used during end-
arterectomy were treated with patch resection and saphe-
nous reconstruction.
Trauma accounted for 13 pseudoaneurysms (11%).
Three (23%) traumatic pseudoaneurysms with acute pre-
sentation underwent open surgical intervention (preopera-
tive imaging not available), and three (23%) with delayed
presentation underwent endovascular treatment (average
diameter, 13.3 mm). The remaining seven (54%) traumatic
pseudoaneurysms (average diameter, 8.3 mm) underwent
medical management, ﬁve with aspirin therapy and two
with observation alone because of the small size of the
aneurysms. One traumatic pseudoaneurysm treated surgi-
cally was re-explored because of bleeding on postoperative
day 2. For the remaining pseudoaneurysms, when trauma
or prior intervention was not clearly responsible, the source
was attributed to idiopathic causes.
DISCUSSION
ECCAs are uncommon and occur in a broad range of
patients from many causes. The patient populations suscep-
tible to trauma and congenital connective tissue diseases
are different from those with atherosclerotic aneurysms or
pseudoaneurysm at endarterectomy sites. Each patient
population and etiology presents its own challenges. Deter-
mining the exact cause of aneurysm formation remains a
challenge.4,9
The most common underlying cause of ECCA is
atherosclerosis, which in past series has been the leading
factor in 37% to 42% of aneurysms.10,11 Trauma has
accounted for 35% to 51% of aneurysms in some series,12,13
whereas pseudoaneurysms at prior endarterectomy sites
have accounted for 26% to 57% of aneurysms in other
series.11,14 The patient population of an institution affects
the mean age at presentation. Those centers that see
more trauma tend to have a lower mean age at presenta-
tion. Our mean age of 61 years is a reﬂection of a balance
between younger patients with trauma or connective tissue
diseases and older patients with atherosclerosis or prior
endarterectomy.
Disorders of connective tissue can cause a number of
vascular complications. The pattern of organ system
involvement and physiology of vascular disease can often
be traced to a single extracellular matrix component.15
Diseases shown to affect the carotid arteries include Marfan
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fecta, and pseudoxanthoma elasticum.16,17 Polycystic
kidney disease and neuroﬁbromatosis, although not
technically connective tissue diseases, can also cause carotid
artery disease.18,19 Common arterial pathologic change
related to these diseases includes dissections, aneurysms,
and occlusive disease. When a predisposing disease is
suspected in a patient with a carotid aneurysm, further
investigation is warranted and should include family his-
tory, pathology consultation, and imaging of other affected
arterial beds. Genetic testing and counseling should be
considered. Open surgical intervention is the standard
treatment for aneurysms caused by these diseases, but
endovascular intervention may play a role. These patients
are at an increased risk of arterial dissection, aneurysm
recurrence, and aneurysm expansion.15
Open surgical intervention has been a ﬁrst-line treat-
ment since Cooper’s initial operation in 1805. The methods
have obviously changed, but even with the increasing avail-
ability of endovascular options, open surgical repair remains
a viable option. Garg et al point out the ﬁve basic options for
open surgical intervention: aneurysm clipping, excision with
primary anastomosis, excision with interposition graft,
extracranial-intracranial bypass, and carotid ligation.12 Liga-
tion carries up to a 25% risk of stroke and 20% mortality
rate,20 so it tends to be used only as a last resort. In our
series, endovascular intervention was used only in the treat-
ment of pseudoaneurysms. This was mainly due to the belief
that the causes of the pseudoaneurysms were self-limited
and could be addressed endovascularly, whereas the causes
of true aneurysms (including connective tissue disease)
were ongoing and could lead to further aneurysmal degen-
eration if treated endovascularly. There was a trend for more
endovascular intervention in more recent cases. Open surgi-
cal intervention was favored when symptoms occurred,
especially mass effect or bleeding.
Both covered and bare metal stents have been used to
treat ECCAs. Bare metal stents can be used alone or com-
bined with aneurysm sac coiling through the stents. Li et al
have proposed criteria that would tend to favor an endovas-
cular approach: aneurysms of the distal cervical internal
carotid or hostile necks due to prior surgery or radiation.13
In our series, the choice between open and endovascular
intervention was more dependent on the type of aneurysm
than on the location. Several series have reported favorable
midterm results after endovascular intervention.13,21
Historically, ECCAs were diagnosed when symptoms
such as cerebrovascular events, cervical masses, or pain
developed. More recently, the diagnosis of asymptomatic
aneurysms has increased with more frequent use of cross-
sectional imaging. In our series, 49% of aneurysms were
asymptomatic and discovered incidentally during imaging.
Prior studies have reported up to 50% of patients present-
ing with neurologic symptoms such as stroke or transient
ischemic attack.14,22,23
The strength of our series is in both the total number
of ECCAs and the varieties of treatment, including medical
therapy with observation. Other large series have focusedon intervention alone without an observation cohort.14,24
The weaknesses of our series include its retrospective
nature, without predeﬁned diagnostic, treatment, or
follow-up algorithms, and the heterogeneity of aneurysms
inherent in a large, retrospective review across distinct
geographic areas. Nonetheless, it is clear from this series
that ECCAs can be successfully and safely treated by both
open and endovascular means and that properly selected
ECCAs canbe treatedwithmedical therapy andobservation.
CONCLUSIONS
ECCAs are uncommon and may be manifested with
varying or no symptoms. All segments of the carotid artery
are susceptible, although the internal is most commonly
affected. Open surgical intervention was more common
in patients with symptoms, true aneurysms, and larger
aneurysms. Patients with pseudoaneurysms were more likely
to undergo endovascular intervention than were patients
with true aneurysms. Nonoperative treatment is safe in
selected patients and tends to occur in smaller aneurysms.AUTHOR CONTRIBUTIONS
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